Polysaccharides polymers for glaucoma treatment-a review

Area of Science:

• Ophthalmology
• Materials Science
• Pharmacology

Background:

• Glaucoma treatment faces challenges with patient adherence to medication regimens.
• Conventional ophthalmic drug delivery systems have significant limitations.
• Polymers-based systems are being developed to improve glaucoma drug delivery.

Purpose of the Study:

• To review pre-clinical and clinical studies on polysaccharide polymers for glaucoma treatment.
• To evaluate the therapeutic outcomes of polysaccharide-based glaucoma drug delivery systems.
• To highlight the potential of polysaccharides in enhancing drug release, bioavailability, and patient compliance.

Main Methods:

• Review of existing literature on polysaccharide polymers in glaucoma treatment.
• Analysis of studies focusing on sustained drug release mechanisms.
• Evaluation of therapeutic outcomes and patient compliance data.

Main Results:

• Polysaccharide polymers (e.g., alginate, chitosan, hyaluronic acid) show promise for sustained ophthalmic drug delivery.
• These polymers enhance ocular surface retention, improving drug absorption and bioavailability.
• Developed systems demonstrate improved efficacy, feasibility, and patient compliance in glaucoma treatment.

Conclusions:

• Polysaccharide-based drug delivery systems offer a promising approach to overcome limitations in glaucoma management.
• Sustained release formulations using polysaccharides can improve treatment adherence and therapeutic outcomes.
• Further research into polysaccharide polymers can lead to more effective glaucoma therapies.